Objective: We investigated the relationship of body mass index at presentation and pituitary status with long-term changes in BMI over a period of 5 years. Study Design: Craniopharyngioma patients (n = 25) attending a tertiary pediatric endocrine center were divided into three groups based on their BMI at presentation [BMI ≥2 standard deviation scores (SDS), 0-1.99 SDS, and <0 SDS) and then analyzed for trends of BMI over a period of up to 5 years. Results: Median (interquartile range) BMI SDS and hypopituitarism at presentation versus at the 5-year follow-up were as follows: BMI SDS ≥2 group (n = 10): 3.55 (0.68), 6/10 versus 3.76 (1.13), 8/10; BMI SDS 0-1.99 group (n = 11): 1.68 (1.05), 3/11 versus 1.64 (2.04), 7/11, and B...
WOS: 000400660600003PubMed: 28418336Background: Intracranial lesions may affect the hypothalamo-hypo...
Background: As a result of hypothalamic involvement and/or treatment-related hypothalamic damage, up...
BACKGROUND: Hypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma (...
Objective: We investigated the relationship of body mass index at presentation and pituitary status ...
An epidemic of pediatric obesity has occurred across the world in recent years. There are subgroups ...
Hypothalamic obesity is an major concern in children treated for craniopharyngioma. Not only the cra...
Objective: Childhood craniopharyngiomas (CP) are often diagnosed after a long duration of history (D...
Objective: Childhood craniopharyngiomas (CP) are often diagnosed after a long duration of history (D...
An epidemic of pediatric obesity has occurred across the world in recent years. There are subgroups ...
Context: Patients with craniopharyngioma suffer from obesity and impaired bone health. Little is kno...
Extreme degrees of obesity may occur in association with hypothalamic tumors, usually after surgical...
PURPOSE: Childhood brain tumor survivors (CBTS) are at risk for developing obesity, which negatively...
Purpose: Childhood brain tumor survivors (CBTS) are at risk of becoming overweight, which has been s...
Background: Hypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma (...
Background/objectives: Hypothalamic obesity (HO) occurs in 50% of patients with the pituitary tumor ...
WOS: 000400660600003PubMed: 28418336Background: Intracranial lesions may affect the hypothalamo-hypo...
Background: As a result of hypothalamic involvement and/or treatment-related hypothalamic damage, up...
BACKGROUND: Hypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma (...
Objective: We investigated the relationship of body mass index at presentation and pituitary status ...
An epidemic of pediatric obesity has occurred across the world in recent years. There are subgroups ...
Hypothalamic obesity is an major concern in children treated for craniopharyngioma. Not only the cra...
Objective: Childhood craniopharyngiomas (CP) are often diagnosed after a long duration of history (D...
Objective: Childhood craniopharyngiomas (CP) are often diagnosed after a long duration of history (D...
An epidemic of pediatric obesity has occurred across the world in recent years. There are subgroups ...
Context: Patients with craniopharyngioma suffer from obesity and impaired bone health. Little is kno...
Extreme degrees of obesity may occur in association with hypothalamic tumors, usually after surgical...
PURPOSE: Childhood brain tumor survivors (CBTS) are at risk for developing obesity, which negatively...
Purpose: Childhood brain tumor survivors (CBTS) are at risk of becoming overweight, which has been s...
Background: Hypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma (...
Background/objectives: Hypothalamic obesity (HO) occurs in 50% of patients with the pituitary tumor ...
WOS: 000400660600003PubMed: 28418336Background: Intracranial lesions may affect the hypothalamo-hypo...
Background: As a result of hypothalamic involvement and/or treatment-related hypothalamic damage, up...
BACKGROUND: Hypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma (...